Escherichia coli (E. coli) is a group of bacteria that cause infections in the gastrointestinal (GI) tract and urinary tract (UTIs). The rise in antimicrobial resistance (AMR) due to antibioticresistant genes (ARGs) linked to E. coli strains that cause UTIs poses a significant threat. Identifying ARGs and resistant strains is crucial for effective treatment. To identify ARGs and classify resistant strains in E. coli utilizing gene expression (GE) data with advanced computational techniques such as feature engineering and transfer learning (TL). In TL, knowledge acquired by the baseline model is transferred to the target domain (BI-LSTMGRU). ARGai 2.0 utilizes the Synthetic Minority Over-sampling Technique (SMOTE) for oversampling the GE dataset to evaluate the effectiveness of the proposed TL framework. Our proposed ARGai 2.0 model achieved a higher classification accuracy of 14% compared to 1D CNN and 11% compared to BI-LSTM-GRU individually. The analysis revealed that genes associated with the nitrate reductase operon (narU, narV, narW, narY, and narZ) exhibit high connectivity and interaction scores, indicating their central role in nitrate metabolism. This aligns with the high enrichment FDR of 3.07E-10 and fold enrichment of 229.28 for pathways related to nitrate reductase complex and nitrite transmembrane transporter activity. ARGai 2.0 successfully detected the significant genes responsible for antibiotic resistance and classified the resistant strains. The gene network analysis highlights the central role of nitrate metabolism genes, while peripheral genes like ansP and yncG are involved in more specialized functions.
Gram-negative ESKAPE pathogens pose major challenges to global public health due to their multidrug resistance and virulence. The present study aimed to study the prevalence and resistance of Gram-negative ESKAPE pathogens at a tertiary care hospital in Eastern India. A retrospective analysis was conducted on 7343 non-duplicate isolates collected between January 2023 and December 2024. The bacterial isolates and their antibiotic susceptibility testing were identified using Kirby–Bauer disk diffusion techniques and the VITEK 2 Compact system, adhering to CLSI 2025 and EUCAST 2024 guidelines. Our findings indicate that Klebsiella pneumoniae was the most common isolate, followed by Pseudomonas aeruginosa, Acinetobacter baumannii complex, and Enterobacter cloacae complex, predominantly affecting male patients aged 18–64 years. Importantly, most of these isolates exhibit increased multidrug resistance (MDR) to several key antibiotics, including β-lactams and carbapenems, which further complicates the treatment process. The analysis of seasonal dynamics revealed an increased abundance of infections in monsoon and post-monsoon periods. These findings will be useful in understanding AMR in hospital environments and in developing strategies to prevent the occurrence and spread of antimicrobial resistance among pathogens.
Polymyxin' E' (Colistin) is considered the last resort therapy against Multidrug resistance (MDR) bacteria, mainly Klebsiella peumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Escherichia coli and play a critical role in causing life-threatening infection, and their prevalence is increasing as a big concern globally. Apart from immunological adaptation, chromosomal mutations and plasmid-mediated genes are mostly associated with this resistance at the molecular level. Therefore, the current review extensively focused on Colistin as a drug in 21st-century antibiotics, the activities spectrum with diverse resistance mechanisms of bacteria against Colistin, and emerging approaches of Colistin from discovery to tackling MDR. In the study, we got to know about the challenges and new developments with old weapons like phage therapy as well as new approaches like Phage display and drug repurposing, in addition to the chromosomal and plasmid-mediated genes that play a role in antimicrobial resistance (AMR). The present study would provide insight into the prognostic aspect of combating MDR.